imee Hardy says her son is in agony. He has battled cancer on and off, and now he's in jeopardy again due to complications from a bone marrow transplant. Doctors believe Brincidofovir could save his life, but the maker of the drug won't provide it. Chimerix is the company that makes Brincidofovir. They're facing a major ethical dilemma because they say there are hundreds if not thousands of people who need it, but if they give it to patients like Josh, it will slow down their efforts to make it widely available. They hope that will happen in 2016 if...